인벤티지랩

389470KOSDAQ자연과학 및 공학 연구개발업

40.5 / 100

Reference Date: 2026-07-24

Financial Score12.0 / 40

News Sentiment16.5 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: Operating Profit is on a declining trend, ROE is below the industry average. Plunged 24.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

InventiZ Lab is a DDS (Drug Delivery System) platform company leveraging microfluidics-based Laminar-FLUIDigm™ technology to develop long-acting injectables and gene delivery solutions. It utilizes the IVL-DrugFluidic® platform for improved new drug development and the IVL-GeneFluidic® platform for LNP formulation services for mRNA vaccines, alongside expanding CDMO (Contract Development and Manufacturing Organization) operations. The company currently produces and sells Durahart SR-3 injectable solution and is advancing multiple drug candidates, including IVL3001, IVL3003, and IVL3004, through various clinical trials.

Number of Employees

73people

Average Salary

44.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

5.00Industry Average 2.521.0Point

2.0x industry avg (risky)

ROE

-28.06Industry Average -32.093.5Point

Below industry avg

Debt Ratio

12.37Industry Average 7.310.5Point

1.7x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲117.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼34.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -91.6% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 3Neutral 3Negative 0Average Sentiment Score 65.8

Neutral
비만치료제 시장 경쟁 ‘2라운드’ 본격화…“투약은 편하고 효과는 ...
비만치료제 시장 경쟁이 심화되고 있으나, 직접적인 영향은 인벤티지랩의 사업 영역과 무관함.
Positive
인벤티지랩 "지질나노입자 플랫폼 연구 학회발표"
인벤티지랩의 mRNA-LNP 대량생산 기술 연구 성과가 국제 학회에서 발표되어 기술적 우위와 시장 경쟁력 강화를 시사합니다.
Positive
인벤티지랩, CRS서 mRNA-LNP 대량생산 플랫폼 기술성과 발표
인벤티지랩이 mRNA-LNP 대량생산 기술성과를 국제 학회에서 발표하며 기술적 우위를 입증했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 30,400Won52-week high 99,50052-week low 28,800

1-month return0.0Point

1m -24.57% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-29